These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

386 related articles for article (PubMed ID: 28065453)

  • 1. Protective Effects of L-Carnitine Against Delayed Graft Function in Kidney Transplant Recipients: A Pilot, Randomized, Double-Blinded, Placebo-Controlled Clinical Trial.
    Jafari A; Khatami MR; Dashti-Khavidaki S; Lessan-Pezeshki M; Abdollahi A; Moghaddas A
    J Ren Nutr; 2017 Mar; 27(2):113-126. PubMed ID: 28065453
    [TBL] [Abstract][Full Text] [Related]  

  • 2. rhErythropoietin-b as a tissue protective agent in kidney transplantation: a pilot randomized controlled trial.
    Coupes B; de Freitas DG; Roberts SA; Read I; Riad H; Brenchley PE; Picton ML
    BMC Res Notes; 2015 Feb; 8():21. PubMed ID: 25643790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A phase I/II, double-blind, placebo-controlled study assessing safety and efficacy of C1 esterase inhibitor for prevention of delayed graft function in deceased donor kidney transplant recipients.
    Jordan SC; Choi J; Aubert O; Haas M; Loupy A; Huang E; Peng A; Kim I; Louie S; Ammerman N; Najjar R; Puliyanda D; Vo A
    Am J Transplant; 2018 Dec; 18(12):2955-2964. PubMed ID: 29637714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of high-dose erythropoietin on graft function after kidney transplantation: a randomized, double-blind clinical trial.
    Sureshkumar KK; Hussain SM; Ko TY; Thai NL; Marcus RJ
    Clin J Am Soc Nephrol; 2012 Sep; 7(9):1498-506. PubMed ID: 22745272
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of cyclosporine A pretreatment of deceased organ donors on kidney graft function (Cis-A-rein): study protocol for a randomized controlled trial.
    Orban JC; Fontaine E; Cassuto E; Baumstarck K; Leone M; Constantin JM; Ichai C;
    Trials; 2018 Apr; 19(1):231. PubMed ID: 29665840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of alternative serum biomarkers with creatinine for predicting allograft function after kidney transplantation.
    Hall IE; Doshi MD; Poggio ED; Parikh CR
    Transplantation; 2011 Jan; 91(1):48-56. PubMed ID: 21441853
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed Graft Function in Kidney Transplantation: Risk Factors and Impact on Early Graft Function.
    Tugmen C; Sert I; Kebabcı E; Murat Dogan S; Tanrısev M; Alparslan C; Kılıcaslan Ayna T; Olmez M; Karaca C
    Prog Transplant; 2016 Jun; 26(2):172-7. PubMed ID: 27207406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of N-acetylcysteine pretreatment of deceased organ donors on renal allograft function: a randomized controlled trial.
    Orban JC; Quintard H; Cassuto E; Jambou P; Samat-Long C; Ichai C
    Transplantation; 2015 Apr; 99(4):746-53. PubMed ID: 25250647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validating Early Post-Transplant Outcomes Reported for Recipients of Deceased Donor Kidney Transplants.
    Potluri VS; Parikh CR; Hall IE; Ficek J; Doshi MD; Butrymowicz I; Weng FL; Schröppel B; Thiessen-Philbrook H; Reese PP
    Clin J Am Soc Nephrol; 2016 Feb; 11(2):324-31. PubMed ID: 26668026
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed Graft Function, Predictive Factors, and 7-Year Outcome of Deceased Donor Kidney Transplant Recipients With Different Immunologic Profiles.
    Quintella AHDS; Lasmar MF; Fabreti-Oliveira RA; Nascimento E
    Transplant Proc; 2018 Apr; 50(3):737-742. PubMed ID: 29661426
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peritransplant eculizumab does not prevent delayed graft function in deceased donor kidney transplant recipients: Results of two randomized controlled pilot trials.
    Schröppel B; Akalin E; Baweja M; Bloom RD; Florman S; Goldstein M; Haydel B; Hricik DE; Kulkarni S; Levine M; Mehrotra A; Patel A; Poggio ED; Ratner L; Shapiro R; Heeger PS
    Am J Transplant; 2020 Feb; 20(2):564-572. PubMed ID: 31452319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of Perioperative Dexmedetomidine on Delayed Graft Function Following a Donation-After-Cardiac-Death Kidney Transplant: A Randomized Clinical Trial.
    Shan XS; Hu LK; Wang Y; Liu HY; Chen J; Meng XW; Pu JX; Huang YH; Hou JQ; Feng XM; Liu H; Meng L; Peng K; Ji FH
    JAMA Netw Open; 2022 Jun; 5(6):e2215217. PubMed ID: 35657627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is plasma and urine neutrophil gelatinase-associated lipocalin (NGAL) determination in donors and recipients predictive of renal function after kidney transplantation?
    Buemi A; Musuamba F; Frederic S; Douhet A; De Meyer M; De Pauw L; Darius T; Kanaan N; Wallemacq P; Mourad M
    Clin Biochem; 2014 Oct; 47(15):68-72. PubMed ID: 25011070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors and outcomes of delayed graft function after living-donor kidney transplantation.
    Redfield RR; Scalea JR; Zens TJ; Muth B; Kaufman DB; Djamali A; Astor BC; Mohamed M
    Transpl Int; 2016 Jan; 29(1):81-7. PubMed ID: 26432507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Delayed graft function: risk factors and the effects of early function and graft survival.
    Miglinas M; Supranaviciene L; Mateikaite K; Skebas K; Kubiliene A
    Transplant Proc; 2013 May; 45(4):1363-7. PubMed ID: 23726573
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction therapy by anti-thymocyte globulin (rabbit) versus basiliximab in deceased donor renal transplants and the effect on delayed graft function and outcomes.
    Foster CE; Weng RR; Piper M; Laugenou K; Ichii H; Lakey J; Malinoski D
    Transplant Proc; 2012 Jan; 44(1):164-6. PubMed ID: 22310605
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind randomised controlled investigation into the efficacy of Mirococept (APT070) for preventing ischaemia reperfusion injury in the kidney allograft (EMPIRIKAL): study protocol for a randomised controlled trial.
    Kassimatis T; Qasem A; Douiri A; Ryan EG; Rebollo-Mesa I; Nichols LL; Greenlaw R; Olsburgh J; Smith RA; Sacks SH; Drage M
    Trials; 2017 Jun; 18(1):255. PubMed ID: 28587616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Allogeneic mesenchymal stem cell as induction therapy to prevent both delayed graft function and acute rejection in deceased donor renal transplantation: study protocol for a randomized controlled trial.
    Sun Q; Hong L; Huang Z; Na N; Hua X; Peng Y; Zhao M; Cao R; Sun Q
    Trials; 2017 Nov; 18(1):545. PubMed ID: 29145879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urine neutrophil gelatinase-associated lipocalin is a marker of graft recovery after kidney transplantation.
    Hollmen ME; Kyllönen LE; Inkinen KA; Lalla ML; Salmela KT
    Kidney Int; 2011 Jan; 79(1):89-98. PubMed ID: 20861824
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Outcomes of standard dose EC-MPS with low exposure to CsA in DCD renal transplantation recipients with DGF.
    Ding C; Xue W; Tian P; Ding X; Pan X; Yan H; Xiang H; Feng X; Hou J; Tian X; Li Y; Zheng J
    Int J Clin Pract Suppl; 2015 May; (183):8-15. PubMed ID: 26176940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.